Anti-BCR-induced Bcl-2 and Bcl-XL levels were not enough to counteract its negative effect on in vitro CD27+ B cells’ survival, neither in CVID patients nor in controls (Supplementary Figure 3). The gene discussed is BCR; the disease is common variable immunodeficiency.